What is the first line therapy for diabetic gastroparesis?

What is the first line therapy for diabetic gastroparesis?

• A. Metoclopramide
• B. Erythromycin
• C. Insulin
• D. Omeprazole

Answer: (A)

Metoclopramide is recognized as the first-line therapy for diabetic gastroparesis due to its prokinetic properties, which enhance gastric motility. Diabetic gastroparesis is a condition characterized by delayed gastric emptying that occurs as a complication of diabetes, often due to autonomic neuropathy affecting the stomach's ability to contract effectively. Metoclopramide works by stimulating the release of acetylcholine, which increases gastric motility and promotes faster gastric emptying. Additionally, it has antiemetic properties that can help alleviate nausea and vomiting associated with the condition. Other treatment options, while potentially useful in specific situations, do not address the underlying slowing of gastric motility as directly as metoclopramide. For instance, erythromycin, although it can also enhance gastric emptying, is typically not used as a first-line medication due to its antibiotic nature and potential for side effects with long-term use. Insulin may help control blood sugar levels in patients with diabetes, but it does not provide relief from the symptoms of gastroparesis. Omeprazole, a proton pump inhibitor, is primarily used to reduce gastric acid and treat acid-related disorders but does not improve gastric motility. Thus, met

Metoclopramide is recognized as the first-line therapy for diabetic gastroparesis due to its prokinetic properties, which enhance gastric motility. Diabetic gastroparesis is a condition characterized by delayed gastric emptying that occurs as a complication of diabetes, often due to autonomic neuropathy affecting the stomach's ability to contract effectively.

Metoclopramide works by stimulating the release of acetylcholine, which increases gastric motility and promotes faster gastric emptying. Additionally, it has antiemetic properties that can help alleviate nausea and vomiting associated with the condition.

Other treatment options, while potentially useful in specific situations, do not address the underlying slowing of gastric motility as directly as metoclopramide. For instance, erythromycin, although it can also enhance gastric emptying, is typically not used as a first-line medication due to its antibiotic nature and potential for side effects with long-term use. Insulin may help control blood sugar levels in patients with diabetes, but it does not provide relief from the symptoms of gastroparesis. Omeprazole, a proton pump inhibitor, is primarily used to reduce gastric acid and treat acid-related disorders but does not improve gastric motility. Thus, met